Antitumor Vaccination of Patients With Glioblastoma Multiforme: A Pilot Study to Assess Feasibility, Safety, and Clinical Benefit

Prognosis of patients with glioblastoma is poor. Therefore, in glioblastoma patients, we analyzed whether antitumor vaccination with a virus-modified autologous tumor cell vaccine is feasible and safe. Also, we determined the influence on progression-free survival and overall survival and on vaccina...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 22; no. 21; pp. 4272 - 4281
Main Authors:	STEINER, Hans Herbert, BONSANTO, Matteo Mario, BAUER, Harald, KIESSLING, Marika, KUNZE, Stefan, SCHIRRMACHER, Volker, HEROLD-MENDE, Christel, BECKHOVE, Philipp, BRYSCH, Michael, GELETNEKY, Karsten, AHMADI, Rezvan, SCHUELE-FREYER, Rebecca, KREMER, Paul, RANAIE, Golamreza, MATEJIC, Dejana
Format:	Journal Article
Language:	English
Published:	Baltimore, MD American Society of Clinical Oncology 01-11-2004 Lippincott Williams & Wilkins
Subjects:	Avulavirus Biological and medical sciences Cancer Vaccines - pharmacology Case-Control Studies Central Nervous System Neoplasms - immunology Central Nervous System Neoplasms - therapy Feasibility Studies Female Glioblastoma - immunology Glioblastoma - therapy Humans Immunohistochemistry Immunotherapy, Active Male Medical sciences Middle Aged Neurology Pilot Projects Prognosis Survival Rate Tumor Cells, Cultured Tumors Tumors of the nervous system. Phacomatoses Antineoplastic agent Human Prevention Malignant glioma Nervous system diseases Cancerology Vaccination Central nervous system disease Feasibility Malignant tumor Glioblastoma multiforme
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!